Financials data is unavailable for this security.
View more
Year on year PharmChem Inc had net income fall -16.95% from 870.43k to 722.89k despite a 3.50% increase in revenues from 5.84m to 6.04m. An increase in the selling, general and administrative costs as a percentage of sales from 45.65% to 50.27% was a component in the falling net income despite rising revenues.
Gross margin | 64.49% |
---|---|
Net profit margin | 19.05% |
Operating margin | 22.94% |
Return on assets | 34.87% |
---|---|
Return on equity | 43.21% |
Return on investment | 42.91% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at PharmChem Inc fell by 1.71m. However, the company earned 638.89k from its operations for a Cash Flow Margin of 10.57%. In addition the company used on investing activities and also paid 2.35m in financing cash flows.
Cash flow per share | 0.24 |
---|---|
Price/Cash flow per share | 14.75 |
Book value per share | 0.5903 |
---|---|
Tangible book value per share | 0.590 |
More ▼
Balance sheet in USDView more
Current ratio | 5.49 |
---|---|
Quick ratio | 5.20 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼